scholarly journals Five Year Outcome in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access

Author(s):  
Tomasz Jakimowicz ◽  
Stanislaw Przywara ◽  
Jakub Turek ◽  
Alison Pilgrim ◽  
Norbert Zapotoczny ◽  
...  
2018 ◽  
pp. 594-614
Author(s):  
Eric K. Hoffer

Interventional radiologists developed and refined the endovascular approaches to maintenance of the permanent arteriovenous vascular accesses that are integral to the provision of hemodialysis for patients with end stage renal disease. As methods of percutaneous arteriovenous fistula creation expand the scope of IR, this chapter reviews the clinical indications and preferences pertinent to dialysis access creation with respect to National Kidney Foundation Recommendations. Accesses remain imperfect, plagued by the development of flow-limiting intimal hyperplastic stenoses, and require monitoring and maintenance to minimize complications, morbidity and mortality. The measures of dialysis access function used in the surveillance of vascular accesses that indicate potential stenosis, and the utility of pre-occlusion recanalization of these stenoses are discussed. Complications specific to dialysis access interventions are also addressed.


The Lancet ◽  
2016 ◽  
Vol 387 (10032) ◽  
pp. 2026-2034 ◽  
Author(s):  
Jeffrey H Lawson ◽  
Marc H Glickman ◽  
Marek Ilzecki ◽  
Tomasz Jakimowicz ◽  
Andrzej Jaroszynski ◽  
...  

2002 ◽  
Vol 40 (3) ◽  
pp. 611-622 ◽  
Author(s):  
Helen Lee ◽  
Braden Manns ◽  
Ken Taub ◽  
William A. Ghali ◽  
Stafford Dean ◽  
...  

2021 ◽  
pp. 021849232110294
Author(s):  
Nitin K Kashyap ◽  
Ahmad F Danish ◽  
Kishan Magatapalli ◽  
Klein Dantis

Patients with the end-stage renal disease require renal replacement therapy in renal transplant, peritoneal dialysis, and intermittent hemodialysis. Hemodialysis remains the primary modality for renal replacement therapy. Excellent vascular access is a mainstay for performing hemodialysis. Here we present a brief review of the various surgical aspects of AV fistula creation. Preoperative physical examination and judicious use of the imaging modalities to define the artery and venous mapping provide a good outcome of the fistula formation. Surgical creation of RC-AVF is preferred for the end-stage renal disease patient. The end-to-side anastomosis between the radial artery and cephalic vein has shown very good results.


2008 ◽  
Vol 41 (6) ◽  
pp. 506-508 ◽  
Author(s):  
A. Frederick Schild ◽  
Eduardo A. Perez ◽  
Erin Gillaspie ◽  
Asha R. Patel ◽  
Karlene Noicely ◽  
...  

2016 ◽  
Vol 29 (4) ◽  
pp. 198-205 ◽  
Author(s):  
Paola De Rango ◽  
Basso Parente ◽  
Luca Farchioni ◽  
Enrico Cieri ◽  
Beatrice Fiorucci ◽  
...  

2017 ◽  
Vol 10 ◽  
pp. 117863291771302 ◽  
Author(s):  
Rabih Nasr ◽  
Sridhar Chilimuri

Optimal preoperative management of dialysis patients remains challenging. Patients with end-stage renal disease (ESRD) have higher mortality in the perioperative setting compared with non-ESRD patients. However, it is well established that dialysis should be done on the day before surgery. Additional dialysis session prior to surgery does not improve outcomes. All dialysis patients should undergo blood work to check electrolytes and especially serum potassium prior to any surgery. Some medications, including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and diuretics, should be stopped prior to surgery to minimize hemodynamic changes during surgery. The dialysis access should be carefully examined for any signs of infection. The arteriovenous fistula or graft should be evaluated for patency. Glycemic control in diabetic ESRD and chronic kidney disease patients is very important, and clinicians should be aware of the risk of bleeding and the appropriate analgesics that can be used in dialysis patients in the perioperative setting. In conclusion, preoperative evaluation in patients with ESRD should be a multidisciplinary approach.


Nephrology ◽  
2017 ◽  
Vol 22 (4) ◽  
pp. 333-334 ◽  
Author(s):  
Chia-Ter Chao ◽  
Chih-Kang Chiang ◽  
Jenq-Wen Huang ◽  
Kuan-Yu Hung ◽  

Sign in / Sign up

Export Citation Format

Share Document